Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Quaker Chemical Corporation is a specialty chemicals business based in the US. Quaker Chemical Corporation shares (KWR) are listed on the NYSE and all prices are listed in US Dollars. Quaker Chemical Corporation employs 4,200 staff and has a trailing 12-month revenue of around 0.00.
|52-week range||$137.41 - $301.50|
|50-day moving average||$241.83|
|200-day moving average||$248.34|
|Wall St. target price||$279.00|
|Dividend yield||$1.56 (0.64%)|
|Earnings per share (TTM)||$2.22|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Quaker Chemical Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Quaker Chemical Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Quaker Chemical Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 108x. In other words, Quaker Chemical Corporation shares trade at around 108x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Quaker Chemical Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.67. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Quaker Chemical Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Quaker Chemical Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $194.6 million.
The EBITDA is a measure of a Quaker Chemical Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.4 billion|
|Operating margin TTM||7.91%|
|Gross profit TTM||$514.5 million|
|Return on assets TTM||2.44%|
|Return on equity TTM||3.1%|
|Market capitalisation||$4.3 billion|
TTM: trailing 12 months
There are currently 1.6 million Quaker Chemical Corporation shares held short by investors – that's known as Quaker Chemical Corporation's "short interest". This figure is 7.3% down from 1.7 million last month.
There are a few different ways that this level of interest in shorting Quaker Chemical Corporation shares can be evaluated.
Quaker Chemical Corporation's "short interest ratio" (SIR) is the quantity of Quaker Chemical Corporation shares currently shorted divided by the average quantity of Quaker Chemical Corporation shares traded daily (recently around 103129.38177183). Quaker Chemical Corporation's SIR currently stands at 15.69. In other words for every 100,000 Quaker Chemical Corporation shares traded daily on the market, roughly 15690 shares are currently held short.
However Quaker Chemical Corporation's short interest can also be evaluated against the total number of Quaker Chemical Corporation shares, or, against the total number of tradable Quaker Chemical Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Quaker Chemical Corporation's short interest could be expressed as 0.09% of the outstanding shares (for every 100,000 Quaker Chemical Corporation shares in existence, roughly 90 shares are currently held short) or 0.1415% of the tradable shares (for every 100,000 tradable Quaker Chemical Corporation shares, roughly 142 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Quaker Chemical Corporation.
Find out more about how you can short Quaker Chemical Corporation stock.
Dividend payout ratio: 32.85% of net profits
Recently Quaker Chemical Corporation has paid out, on average, around 32.85% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.65% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Quaker Chemical Corporation shareholders could enjoy a 0.65% return on their shares, in the form of dividend payments. In Quaker Chemical Corporation's case, that would currently equate to about $1.56 per share.
While Quaker Chemical Corporation's payout ratio might seem fairly standard, it's worth remembering that Quaker Chemical Corporation may be investing much of the rest of its net profits in future growth.
Quaker Chemical Corporation's most recent dividend payout was on 29 April 2021. The latest dividend was paid out to all shareholders who bought their shares by 14 April 2021 (the "ex-dividend date").
Quaker Chemical Corporation's shares were split on a 3:2 basis on 30 July 1990. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Quaker Chemical Corporation shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Quaker Chemical Corporation shares which in turn could have impacted Quaker Chemical Corporation's share price.
Over the last 12 months, Quaker Chemical Corporation's shares have ranged in value from as little as $137.4139 up to $301.5026. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Quaker Chemical Corporation's is 1.4953. This would suggest that Quaker Chemical Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Quaker Chemical Corporation develops, produces, and markets various formulated chemical specialty products for a range of heavy industrial and manufacturing applications. It operates through four segments: Americas; Europe, Middle East, and Africa; Asia/Pacific; and Global Specialty Businesses. The company offers metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, metal finishing fluids, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids, and surface treatment chemicals. It also provides chemical management services. The company serves steel, aluminum, automotive, aerospace, offshore, can, mining, and metalworking companies. The company was formerly known as Quaker Chemical Products Corporation and changed its name to Quaker Chemical Corporation in August 1962. Quaker Chemical Corporation was founded in 1918 and is headquartered in Conshohocken, Pennsylvania.
Everything we know about the Krispy Kreme IPO, plus information on how to buy in.
Everything we know about the Day One Biopharmaceuticals IPO, plus information on how to buy in.
Everything we know about the Enact Holdings IPO, plus information on how to buy in.
Everything we know about the Solid Power IPO, plus information on how to buy in.
Everything we know about the Paymentus Holdings IPO, plus information on how to buy in.
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
Everything we know about the Ximalaya IPO, plus information on how to buy in.
Everything we know about the Zeta Global Holdings Corp IPO, plus information on how to buy in.
Everything we know about the Paycor HCM IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.